SHAREEFA SALEH: Open Payments
NPI 1255929576 · WALNUT CREEK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,673 in 107 payments from 19 companies in 2025. Trend: 2023 $1,142 · 2024 $2,614 · 2025 $2,673
Food & beverage: $2,673
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $398 |
| Incyte Corporation | 16 | $389 |
| Lilly USA, LLC | 11 | $312 |
| UCB, Inc. | 9 | $288 |
| Regeneron Healthcare Solutions, Inc. | 7 | $271 |
| Galderma Laboratories, L.P. | 16 | $269 |
| Organon LLC | 6 | $130 |
| Arcutis Biotherapeutics, Inc. | 5 | $114 |
| Novartis Pharmaceuticals Corporation | 4 | $96 |
| Janssen Biotech, Inc. | 3 | $82 |
Products named: OPZELURA, DUPIXENT, Bimzelx, SKYRIZI, NEMLUVIO, TALTZ, Zoryve, TREMFYA.
Industry payments across CA — which companies pay providers there.
